Neurim not fit for purpose, but are SPCs?
On 9 July 2020, the CJEU followed the Advocate General’s recommendation in Santen (see Is Neurim fit for purpose? Santen AGO on SPCs for...
Edit Profile
Sarah Naisby
Associate at Freshfields Bruckhaus Deringer
London, United Kingdom
- +44 20 7427 3469
- sarah.naisby@freshfields.com
- http://www.freshfields.com/
About Me
Sarah has experience of a range of contentious and non-contentious IP, IT, data protection and commercial work.
Sarah Naisby's Passles
Is Neurim fit for purpose? Santen AGO on SPCs for second medical use suggests not
The Neurim decision opened the door for obtaining SPCs for second medical use patents. Although welcomed by innovators, the judgment was...
UK Government publishes general guidance on IP rights and data protection post-Brexit
On 6 March 2018, the UK government published a technical note on its approach to certain separation issues that are to be agreed as part...
In preparation for the launch of 5G, the EC has issued guidance on the licensing of SEPs. Controversial provisions on use-based licence models and mandatory licensing are not included.
On Wednesday, the European Commission (EC) issued guidance on the licensing of standard essential patents (SEPs), being patents that...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
